StockNews.com cut shares of Adient (NYSE:ADNT – Free Report) from a buy rating to a hold rating in a report issued on Friday morning.
Several other equities analysts have also recently commented on the company. Wolfe Research began coverage on Adient in a report on Thursday, September 5th. They issued a “peer perform” rating for the company. Bank of America lowered shares of Adient from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $30.00 to $24.00 in a research report on Thursday, November 21st. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $24.00 price target on shares of Adient in a research note on Tuesday, September 10th. Morgan Stanley lowered their price objective on Adient from $21.00 to $19.00 and set an “underweight” rating for the company in a research report on Thursday, November 14th. Finally, Wells Fargo & Company cut Adient from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $27.00 to $20.00 in a report on Monday, December 16th. One analyst has rated the stock with a sell rating and nine have issued a hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $23.50.
Check Out Our Latest Research Report on Adient
Adient Stock Performance
Adient (NYSE:ADNT – Get Free Report) last posted its quarterly earnings data on Friday, November 8th. The company reported $0.68 EPS for the quarter, topping analysts’ consensus estimates of $0.56 by $0.12. Adient had a return on equity of 6.86% and a net margin of 0.12%. The business had revenue of $3.56 billion for the quarter, compared to analyst estimates of $3.47 billion. During the same period in the previous year, the company posted $0.51 earnings per share. The firm’s revenue for the quarter was down 3.7% on a year-over-year basis. On average, sell-side analysts anticipate that Adient will post 2.04 EPS for the current year.
Insider Transactions at Adient
In other news, EVP James Conklin sold 11,500 shares of the business’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $20.25, for a total value of $232,875.00. Following the completion of the transaction, the executive vice president now owns 51,829 shares of the company’s stock, valued at $1,049,537.25. The trade was a 18.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.30% of the company’s stock.
Institutional Trading of Adient
Large investors have recently bought and sold shares of the business. US Bancorp DE increased its holdings in Adient by 583.8% during the 3rd quarter. US Bancorp DE now owns 1,860 shares of the company’s stock worth $42,000 after purchasing an additional 1,588 shares in the last quarter. Signaturefd LLC lifted its stake in Adient by 493.8% in the 3rd quarter. Signaturefd LLC now owns 2,191 shares of the company’s stock valued at $49,000 after acquiring an additional 1,822 shares in the last quarter. KBC Group NV boosted its position in Adient by 51.8% during the 3rd quarter. KBC Group NV now owns 3,328 shares of the company’s stock worth $75,000 after acquiring an additional 1,136 shares during the last quarter. Covestor Ltd grew its stake in shares of Adient by 23.2% during the 3rd quarter. Covestor Ltd now owns 5,482 shares of the company’s stock worth $124,000 after acquiring an additional 1,032 shares in the last quarter. Finally, Algert Global LLC bought a new position in shares of Adient during the 2nd quarter worth approximately $227,000. 92.44% of the stock is owned by institutional investors.
About Adient
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
See Also
- Five stocks we like better than Adient
- Investing in Travel Stocks Benefits
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- How is Compound Interest Calculated?
- CarMax Gets in Gear: Is Now the Time to Buy?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.